Pharmaceutical combinations comprising RDEA119/BAY 869766 for the treatment of specific cancers

Details for Australian Patent Application No. 2010224044 (hide)

Owner Ardea Biosciences, Inc.

Inventors Chapman, Mark S.

Agent Davies Collison Cave

Pub. Number AU-A-2010224044

PCT Pub. Number WO2010/105110

Priority 61/159,403 11.03.09 US

Filing date 11 March 2010

Wipo publication date 16 September 2010

International Classifications

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/185 (2006.01) - Acids

A61K 31/4188 (2006.01)

A61K 31/436 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/7064 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 September 2011 PCT application entered the National Phase

  PCT publication WO2010/105110 Priority application(s): WO2010/105110

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010224045-Drive mechanism for a solar concentrator assembly

2010224037-Compositions and methods for prophylaxis and treatment of addictions